KCT0007323Not yet recruiting
Untitled Trial
Efficacy and durability of early Quadraple with lobeglitazone and empagliflozin to Uncontrolled type 2 diabetes under metformin and DPP4 inhibitors
Yonsei University Health System, Severance HospitalPhase 3Korean Clinical Trial Registry
VerifiedKorean Clinical Trial Registry
Study focus
- Disease/Condition
- type 2 diabetes
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Yonsei University Health System, Severance Hospital
- Funder
- Chong Kun Dang
- Location
- South Korea
Timeline & enrollment
- Phase
- Phase 3
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- Korean Clinical Trial Registry
- Trial ID
- KCT0007323
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for KCT0007323 through Pure Global AI's free database. This Phase 3 trial is sponsored by Yonsei University Health System, Severance Hospital and is currently Not yet recruiting. The study focuses on type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Korean Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.